320 related articles for article (PubMed ID: 9397657)
1. Oral treatment options for onychomycosis.
Joseph WS
J Am Podiatr Med Assoc; 1997 Nov; 87(11):520-31. PubMed ID: 9397657
[TBL] [Abstract][Full Text] [Related]
2. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Gupta AK
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacoeconomic approach to onychomycosis therapy].
Glad'ko VV; Tarasenko GN
Voen Med Zh; 2002 Jun; 323(6):54-5. PubMed ID: 12140994
[No Abstract] [Full Text] [Related]
4. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Gupta AK
Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
[TBL] [Abstract][Full Text] [Related]
5. Onychomycosis: improved cure rates with itraconazole and terbinafine.
Harrell TK; Necomb WW; Replogle WH; King DS; Noble SL
J Am Board Fam Pract; 2000; 13(4):268-73. PubMed ID: 10933291
[TBL] [Abstract][Full Text] [Related]
6. Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Gupta AK
J Am Podiatr Med Assoc; 2002 May; 92(5):272-86. PubMed ID: 12015408
[TBL] [Abstract][Full Text] [Related]
7. Treating onychomycosis.
Rodgers P; Bassler M
Am Fam Physician; 2001 Feb; 63(4):663-72, 677-8. PubMed ID: 11237081
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Rosen T; Stein Gold LF
Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
[TBL] [Abstract][Full Text] [Related]
9. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Angello JT; Voytovich RM; Jan SA
Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
[TBL] [Abstract][Full Text] [Related]
10. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
[TBL] [Abstract][Full Text] [Related]
12. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Gupta AK; Lambert J
Int J Dermatol; 1999 Sep; 38 Suppl 2():53-64. PubMed ID: 10515529
[No Abstract] [Full Text] [Related]
14. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Jansen R; Redekop WK; Rutten FF
Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
[TBL] [Abstract][Full Text] [Related]
15. Oral therapeutic agents in fungal nail disease.
Roberts DT
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S78-81. PubMed ID: 8077514
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis--a different perspective.
Epstein E
West J Med; 1997 Jul; 167(1):52-3. PubMed ID: 9265870
[No Abstract] [Full Text] [Related]
17. Management of onychomycosis in children.
Gupta AK; De Rosso JQ
Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
[TBL] [Abstract][Full Text] [Related]
18. Therapies for the treatment of onychomycosis.
Gupta AK; Paquet M; Simpson FC
Clin Dermatol; 2013; 31(5):544-54. PubMed ID: 24079583
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole and terbinafine in perspective. From petri dish to patient.
De Doncker P; Gupta AK
Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
[TBL] [Abstract][Full Text] [Related]
20. Contempo 1997: dermatology.
Del Rosso JQ
JAMA; 1997 Oct; 278(14):1148; author reply 1149. PubMed ID: 9326467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
